当前位置：首页 > 文献互助 > 互助详情

Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction …复制

用户anbt0_mWgNQY 1小时前 24 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-07-24 10:44:42 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

MM Abdeljawad, MT Hasan, A Fareed…
The Journal of …, 2025
Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a global public health concern. Fibroblast growth factor 21 (FGF21), a liver hormone, is gaining interest because of its ability to regulate metabolism and improve MASLD. In this network meta-analysis, we investigated the efficacy of these treatments in treating MASLD. A comprehensive search was conducted across electronic databases, including PubMed, Scopus, the Cochrane Library, and Web of Science, till August 2025. We used R software to …

上一篇：Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis

下一篇：Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer

互助时间线

2026-07-17 10:57:06 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-07-17 10:44:42 [上传文件]

jodie0105上传了文件(pdf 3.44 MB), 求助状态变成 待确认

2026-07-17 10:14:57 [发起求助]

最新发布的求助

Long-term safety and efficacy of intracortical microstimulation in humans 3分钟前
等离子表面改性实现原位生长高分辨率钙钛矿发光二极管 20分钟前
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial 31分钟前
Apatinib combined with capecitabine plus temozolomide versus sunitinib in advanced gastroenteropancreatic neuroendocrine tumours: a propensity score-matched real-world study 37分钟前
Biomimetic Shell–Core Nanoparticles Loaded With Apatinib for Dual Starvation and Chemodynamic Combination Therapy of Lung Cancer 38分钟前
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis 47分钟前
Cemiplimab Plus Chemotherapy Versus Chemotherapy in Advanced NSCLC: 5-Year Results From Phase 3 EMPOWER-Lung 3 Part 2 Trial 53分钟前
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer 55分钟前
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial 1小时前
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer 1小时前
Efficacy and Safety of Fibroblast Growth Factor 21 (FGF21) Analogs in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction … 1小时前
Efimosfermin, a Fibroblast Growth Factor 21 Analogue for Metabolic Dysfunction-Associated Steatohepatitis 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com